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ABSTRACT 
Hepatocellular carcinoma (HCC) is a frequent and fatal human cancer with poor diagnosis that accounts for over 
half a million deaths each year worldwide. Elaeagnus angustifolia L. known as oleaster has a wide range of phar-
macological activities. This study aimed to investigate the chemopreventive effect of aqueous extract of E. an-
gustifolia fruit (AEA) against diethylnitrosamine (DEN)-induced HCC in rats. HCC was induced in rats by a single 
injection of DEN (200 mg/kg) as an initiator. After two weeks, rats were orally administered 2-acetylaminofluo-
rene or 2-AAF (30 mg/kg) as a promoter for two weeks. Oleaster-treated rats were orally pretreated with the 
increasing doses of AEA two weeks prior to DEN injection that continued until the end of the experiment. In the 
current study, a significant decrease in serum biomarkers of liver damage and cancer, including alfa-fetoprotein 
(AFP), gamma glutamyl transpeptidase (GGT), alanine transaminase (ALT), and aspartate transaminase (AST) 
was observed in AEA-treated rats when compared to HCC rats. Furthermore, the oleaster extract exhibited in vivo 
antioxidant activity by elevating reduced glutathione (GSH) contents as well as preventing lipid peroxidation in 
the liver tissues of DEN-treated rats. The relative weight of liver, a prognostic marker of HCC, was also reduced 
in oleaster-treated rats. To conclude, our results clearly demonstrated that oleaster fruit possesses a significant 
chemopreventive effect against primary liver cancer induced by DEN in rats. It can be suggested that the preven-
tive activity of oleaster against hepatocarcinogenesis may be mediated through the antioxidant, anti-inflammation, 
and antimutagenic effects of the fruit. 
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INTRODUCTION 
Primary liver cancer or hepatocellular car-
cinoma (HCC) is the fifth most common ma-
lignancy, with 0.25–1 million new cases diag-
nosed annually in the world (Guo and Wang, 
2009; Frau et al., 2013). Currently, there is no 
proven effective chemotherapy or surgical in-
tervention for HCC and a lot of focus has been 
put on cancer preventive strategies as an ac-
ceptable approach for controlling the HCC in-
cidence. Chemoprevention is one of these 
strategies, which means the use of natural 
products, chemicals or their combinations to 
reduce the risk or delay the onset of cancer 
(Singh et al., 2014). Chemoprevention inter-
feres with the different stages of carcinogene-
sis, i.e. initiation, promotion, and progression 
and decreases the risk of tumor formation. 
Several strategies have been used for HCC 
chemoprevention, including immunization 
against hepatitis B virus (HBV), antiviral 
therapy in patients with chronic hepatitis B or 
C virus, prescribing drugs such as statins, and 
the use of selected dietary agents like coffee, 
vitamin E and fish oil (Bravi et al., 2009; 
Chang et al., 2009; Demierre et al., 2005; Lai 
and Yuen, 2013; Sawada et al., 2012; Singh et 
al., 2014). In addition, medicinal herbs and 
phytochemicals play an essential role in HCC 
chemoprevention and they have become 
known as a most promising and potentially 
cost-effective approach to prevent this ag-
gressive cancer (Okano et al., 2011; Stagos et 
al., 2012). 
Elaeagnus angustifolia L. (oleaster, Rus-
sian olive, wild olive, silver berry) is a medic-
inal plant from Elaeagnacea family. The fruit 
of E. angustifolia has been used in traditional 
and folklore medicine of different countries 
for the treatment of various diseases, includ-
ing rheumatoid arthritis, osteoporosis, 
asthma, diarrhea, and female aphrodisiac. 
Oleaster has also been used in Iranian folk 
medicine as a hepatoprotective and anti-in-
flammatory agent (Farzaei et al., 2015). Re-
cent findings show that the fruit possesses 
various pharmacological and therapeutic ef-
fects such as antioxidant, anti-inflammation, 
antitumour, antimutagenic, antibacterial, anti-
fungal, and gastroprotective effects (Amiri 
Tehranizadeh et al., 2016; Faramarz et al., 
2015; Hamidpour et al., 2016; Panahi et al., 
2016). 
Primary liver cancer is a prototype of in-
flammation-associated cancer and chronic 
liver diseases are the most common causes of 
HCC. Furthermore, free radical formation and 
oxidative DNA damage have a key role in 
hepatocellular carcinogenesis (Aravalli et al., 
2013). Considering the antioxidant, anti-in-
flammatory and antimutagenic effects of ole-
aster; this study was designed to evaluate the 
chemopreventive effect of aqueous extract of 
E. angustifolia fruit (AEA) against diethyl-
nitrosamine (DEN)-induced hepatocellular 
carcinoma in rats. DEN is a potent hepatic 
carcinogen that has extensively been used as 
an experimental carcinogen in cancer biology 
research to induce HCC or different types of 
benign and malignant tumors in rodents 
(Healy et al., 2015). 
 
MATERIALS AND METHODS 
Chemicals 
2-Acetylaminofluorene (2-AAF), bovine 
serum albumin (BSA), thiobarbituric acid, 
and DEN were purchased from Sigma-Al-
drich Co. (Taufkirchen, Germany). All other 
chemicals were of the highest commercial 
grade available. 
 
Preparation of plant extract 
E. angustifolia fruits were collected from 
Ardabil Province, Iran. The collected fruits 
were scientifically approved by the Depart-
ment of Botany, Shahid Beheshti University 
of Medical Sciences (SBUMS) and a voucher 
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sample was preserved for reference in 
SBUMS Herbarium (Voucher number: 1056). 
Then, the different parts of the fruits, includ-
ing peel, flesh, and seed were separated, 
dried, and powdered. After that the extract 
was prepared by the maceration of the powder 
(100 g) with 900 mL distilled water for 30 
min. Accordingly, the fruit extract was fil-
tered and concentrated to 100 mL, then stored 
at -20 °C. The moisture levels of the extract 
were determined by placing 2 g of the final 
extract in an oven at 60–65 °C for 72 h and 
were then weighed. Weight loss was used as 
the moisture indicator. The final extract con-
tained 24 % water, which was dissolved in 
distilled water at the desired concentrations 
just before use (Pourahmad et al., 2010). 
 
Determination of total polyphenol content 
Total polyphenol content was determined 
by spectrophotometry, using gallic acid as the 
standard based on the Folin–Ciocalteu method 
as previously described (Gholami et al., 2017). 
 
Animals 
Male Sprague-Dawley rats weighing 180 
to 200 g were housed in ventilated plastic 
cages over PWI 8-16 hardwood bedding. 
There were 12 air changes per h, 12 h light 
photoperiods, an environmental temperature 
of 21–23 °C, and a relative humidity of 50–
60 %. The animals were fed a standard nor-
mal chow diet and given tap water ad libitum. 
Principles of laboratory animal care (NIH 
publication No. 85-23, revised 1985) were 
followed. All experiments were conducted ac-
cording to the ethical standards and protocols 
approved by the Committee of Animal Exper-
imentation of Zanjan University of Medical 
Sciences, Zanjan, Iran (protocol approval 
number: A-12-501-24). 
 
Hepatocarcinogenesis model 
The experimental model of HCC was in-
duced in rats by DEN as the initiator and 2-
AAF as the promoter of hepatocarcinogenesis 
according to the protocol described previ-
ously with a few modifications (Espandiari et 
al., 2005). Briefly, rats were fasted for 96 
hours and then were refed for 24 hours as a 
proliferative stimulant. Afterward, rats were 
injected only a single intraperitoneally (i.p.) 
dose of DEN (200 mg/kg body weight) for in-
itiating hepatocarcinogenesis. After two 
weeks, liver cancer development was pro-
moted with a once-daily oral administration 
of 2-AAF (30 mg/kg body weight) for two 
weeks. HCC was confirmed by histopatholog-
ical evaluations and the measurement of liver 
damage and cancer markers, including alfa-
fetoprotein (AFP), gamma glutamyl transpep-
tidase (GGT), alanine transaminase (ALT), 
and aspartate transaminase (AST) (Seydi et 
al., 2016). 
 
Experimental design 
As shown in Figure 1, rats were randomly 
divided into six different groups of six rats 
each (n = 6). Group 1 (Control) animals fed 
with standard diet and served as a normal con-
trol, which injected with the single dose of sa-
line. Group 2 were normal animals that 
treated only with daily oral dose of AEA 
(600 mg/kg body weight) from the beginning 
of the experiment. Group 3 (HCC) rats served 
as untreated HCC animals as described be-
fore. Test group animals (Groups 4-6) were 
pretreated with the increasing doses of AEA 
(200, 400, and 600 mg/kg body weight, re-
spectively) two weeks prior to DEN injection 
that continued until the end of the study. The 
different concentrations of the extract were 
selected based on previous investigations and 
were administered orally once daily using an 
intragastric tube for 8 weeks (Ahmadiani et 
al., 2000; Wu et al., 2001).
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Figure 1: Experimental design. b.wt.: body weight; i.p.: intraperitoneal; p.o.: per os (orally) 
 
 
Sample preparations 
On three different time points, animals 
were anaesthetized by ether inhalation and 
blood was collected from the orbital sinus and 
centrifuged at 1500 x g for 20 minutes at 4 °C 
to obtain serum for biochemical analysis. At 
the end of the experimental period, body 
weights of the animals were recorded and rats 
were sacrificed. Then, the liver tissues were 
quickly taken, weighed, and frozen for the de-
termination of hepatic oxidative stress mark-
ers. Frozen liver samples were homogenized 
in ice-cold Tris-HCL buffer (150 mM, pH 
7.4) (Amin et al., 2011). The relative liver 
weight was calculated as the percentage ratio 
of liver weight to the body weight. 
 
Evaluation of biochemical parameters 
Serum AFP is one of the most frequent di-
agnostic markers for HCC, which was deter-
mined by Calbiotech AFP ELISA Kit (Amin 
et al., 2011). The activities of biochemical 
markers of liver damage, including GGT, 
ALT, and AST were determined by commer-
cially available enzyme kits (Pars Azmoon, 
Tehran, Iran) (Mirmohammadlu et al., 2015). 
The assays were performed according to the 
protocols supplied with the kits. 
 
Determination of protein concentration 
The concentration of liver protein was 
measured by the Coomassie blue protein- 
binding method using BSA as the standard 
(Franciscato et al., 2009). 
 
Determination of hepatic oxidative stress 
markers 
Hepatic GSH contents were estimated in 
liver homogenate by a spectrophotometric 
method using dithiobis-2-nitrobenzoic acid 
(DTNB) as the indicator of GSH and ex-
pressed as µg/mg protein. The intensity of the 
yellow color produced in the samples was rec-
orded at 412 nm with a UV spectrophotome-
ter (Infinite M200, TECAN) (Riener et al., 
2002). 
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The level of malondialdehyde (MDA) as 
one of the important markers of hepatic lipid 
peroxidation was estimated in liver homoge-
nate by reading the absorbance of the super-
natant layer at 532 nm with an ELISA reader 
instrument (Infinite M200, TECAN). MDA 
levels were presented as µg/mg protein (Mi-
hara and Uchiyama, 1978). 
 
Statistical analysis 
The homogeneity of variances was tested 
using Levene’s test. The results were ana-
lyzed using one-way analysis of variance 
(ANOVA) followed by Tukey’s HSD as the 
post hoc test. The data were presented as the 
mean±SD (n=6). The results with level of sig-
nificance (P<0.05) were regarded as signifi-
cant. 
 
RESULTS 
Total phenolic content 
Total phenolic content was found to be 
55.12 ± 2.68 mg gallic acid equivalents 
(GAE) per gram of AEA (mg of GAE/g of 
plant extract). The given values are mean±SD 
of three different determinations. 
 
Effects of AEA on serum biochemical  
parameters 
AFP level has been widely used clinically 
as a tumor marker for HCC that was markedly 
enhanced in DEN-treated rats compared with 
normal animals at the end of the experiment 
(P<0.001). As shown in Figure 2(A), the ele-
vation in the serum marker of liver cancer was 
effectively decreased in AEA-treated rats. In 
the present study, the activities of GGT, ALT, 
and AST were also significantly increased in 
HCC rats as compared to normal rats. As can 
be seen in Figure 2(B-D), the oral pretreat-
ment of different concentrations of AEA to 
HCC rats caused a significant reduction in the 
serum markers of liver injury. Interestingly, 
AEA at the concentration of 400 mg/kg body 
weight daily acted more powerful than the 
other concentrations in attenuating the mark-
ers of liver damage and cancer (Figure 2). It 
can be also seen that the oral administration 
of AEA (600 mg/kg body weight/day) to nor-
mal rats (Group 2) did not change the biochem-
ical markers (Figure 2). 
 
Effects of AEA on the hepatic markers of 
oxidative stress 
GSH and its related antioxidant defense 
system are required to neutralize free radicals 
such as electrophilic carcinogens and to coun-
teract oxidative stress. As presented in Figure 
3, liver GSH levels were reduced in HCC rats 
compared to normal animals (P<0.001). 
Moreover, MDA levels as a reliable marker of 
lipid peroxidation were increased in the livers 
of DEN-treated rats compared with those of 
normal rats (P<0.001) (Figure 4). In the cur-
rent study, the oral administration of the ole-
aster extract to HCC rats caused a rise in GSH 
levels as well as a fall in lipid peroxidation 
(Figures 3, 4). Again, the concentration of 
400 mg/kg body weight/day was more effec-
tive than the other concentrations in decreas-
ing the hepatic oxidative stress markers (Fig-
ures 3, 4). It was also shown that the treatment 
of normal rats (Group 2) with AEA (600 mg/ 
kg body weight daily) did not alter the oxida-
tive stress markers (Figures 3, 4). 
 
Effects of AEA on relative liver weight 
As indicated in Figure 5, the relative liver 
weight of HCC rats was increased compared 
with normal animals at the end of the study 
(P<0.05). In addition, the pretreatment of 
AEA (400 mg/kg body weight daily) to HCC 
rats caused a significant decrease in relative 
liver weight (P<0.05). Again, the oral admin-
istration of AEA (600 mg/kg body weight/ 
day) to normal rats (Group 2) did not affect 
the relative liver weight (Figure 5). 
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Figure 2: Effects of the oleaster extract (AEA) on serum biochemical parameters: (A) AFP, (B) 
GGT, (C) ALT, and (D) AST. Values are presented as mean±SD. * P<0.05, ** P<0.01, *** P<0.001 
compared to normal group in corresponding time; Ф P<0.05, ФФ P<0.01, ФФФ P<0.001 compared to 
HCC rats in corresponding time; # P<0.05, ## P<0.01 compared to the previous concentration 
 
 
Figure 3: Effects of the oleaster extract (AEA) on hepatic GSH contents. Values are presented as 
mean±SD. *** P<0.001 compared to normal group; ФФ P<0.01, ФФФ P<0.001 compared to HCC rats; 
# P<0.05 compared to the previous concentration 
EXCLI Journal 2017;16:1046-1056 – ISSN 1611-2156 
Received: April 25, 2017, accepted: June 3, 2017, published: July 18, 2017 
 
 
1052 
 
Figure 4: Effects of the oleaster extract (AEA) on liver lipid peroxidation. MDA formation as the 
marker of lipid peroxidation was expressed as µg/mg protein. Values are presented as mean±SD. *** 
P<0.001 compared to normal group; Ф P<0.05, ФФ P<0.01, ФФФ P<0.001 compared to HCC rats; # 
P<0.05 compared to the previous concentration 
 
 
 
Figure 5: Effects of the oleaster extract (AEA) on relative liver weight. Values are presented as 
mean±SD. * P<0.05 compared to normal group; Ф P<0.05 compared to HCC rats; # P<0.05 compared 
to the previous concentration 
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DISCUSSION 
This is the first report showing chemo- 
preventive effect of oleaster fruit in DEN-in-
duced hepatocellular carcinoma in rats. In this 
study, the pretreatment of oleaster to HCC 
rats caused a remarkable reduction in the se-
rum markers of liver damage and cancer. Se-
rum AFP level is the golden standard among 
diagnostic markers for HCC (Chou et al., 
2017; Park et al., 2017). 
AFP is a glycoprotein that is synthesized 
during early foetal life and after birth its se-
rum concentration falls quickly. It has been 
suggested that AFP acts as a transport mole-
cule for many ligands such as heavy metals, 
bilirubin, and many xenobiotics. Further-
more, AFP has a role in the regulation of cell 
proliferation and an immunosuppressive ac-
tivity (Terentiev and Moldogazieva, 2006). 
Elevated AFP serum levels are only seen in 
certain tumors (e.g. HCC), non-tumoral con-
ditions (e.g. cirrhosis), and maternal serum 
during pregnancy. In the current investiga-
tion, the elevated level of AFP was markedly 
decreased by the oleaster extract. 
GGT, ALT, and AST are also the most 
widely used HCC tumor markers. GGT is a 
cell surface enzyme that involves in glutathi-
one metabolism. Its main function is to sus-
tain cysteine levels in the body to conserve in-
tracellular homeostasis of oxidative stress. 
GGT expression in tumor cells provides a se-
lective advantage to the cells during tumor 
promotion and enables them to preserve ele-
vated levels of intracellular GSH. Therefore, 
it has been suggested that GGT is an inde-
pendent prognostic indicator in patients with 
HCC (Sadeeshkumar et al., 2016; Wu et al., 
2016). Data in our study indicated that the 
oral administration of oleaster to DEN- 
treated rats reduced GGT, ALT, and AST ac-
tivities. 
Glutathione and glutathione-related en-
zymes play a pivotal role in the metabolism 
and detoxification of free radicals and car-
cinogenic compounds. They are also involved 
in the regulation of carcinogenic mechanisms 
and cancer cell death (Ortega et al., 2011). It 
has been reported that GSH levels and the ac-
tivities of GSH-dependent enzymes in the 
liver tissues of HCC patients were decreased 
due to the impairment of antioxidant defense 
system (Czeczot et al., 2006, Lee et al., 2007). 
Our results clearly demonstrated that the ole-
aster extract counteracted DEN-induced oxi-
dative stress and restored GSH levels in the 
liver of oleaster-treated rats. 
Lipid peroxidation, a reliable marker of 
oxidative stress, is a well-defined mechanism 
of cellular damage in different pathological 
conditions. MDA is the end product of lipid 
peroxidation, which is implicated in the pro-
motion and progression stages of carcinogen-
esis (Onlom et al., 2017). As presented in Fig-
ure 4, hepatic MDA levels were excellently 
reduced by the oleaster fruit extract. Finally, 
our results showed that the oleaster extract 
prevented the increase in relative liver weight 
as a prognostic marker of HCC. 
The fruit of oleaster has high nutritional 
values and contains essential amino acids, 
carbohydrates, minerals, and vitamins A, C, 
E, and K (Farzaei et al., 2015). In addition, a 
wide variety of bioactive compounds have 
been identified in E. angustifolia fruit involv-
ing in its broad spectrum of pharmacological 
effects. Oleaster fruit contains different kinds 
of phenolic acids and flavonoids such as 4- 
hydroxybenzoic acid, 4-hydroxycinnamic 
acid, benzoic acid, caffeic acid, and isorham-
netin (Farzaei et al., 2015). Dietary phenolics 
or polyphenols are secondary metabolites of 
plants found in different kinds of fruits and 
vegetables. It has been demonstrated that the 
different classes of polyphenols such as flavo-
noids and phenolic acids have numerous ben-
efits for human health and a protective role 
against various diseases (Tsao, 2010). In re-
cent years, there has been a considerable in-
terest in their potential therapeutic use as 
chemopreventive agents. Several in vitro and 
in vivo studies have shown that plant polyphe-
nols possess protective effects against the de-
velopment and growth of liver cancer sug-
gesting that these natural compounds are 
promising candidate agents for HCC chemo-
prevention. They reverse, suppress or prevent 
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the different steps of hepatocarcinogenesis 
through various mechanisms (Stagos et al., 
2012). In the present study, the extract was 
prepared from whole fruit and more than 5 % 
of the total weight related to polyphenols. 
Therefore, it can be concluded that the chem-
opreventive activity of oleaster may be, at 
least partly, mediated through the anti-car-
cinogenic properties of polyphenolic com-
pounds. 
It is strongly believed that inflammation- 
mediated processes and oxidative stress con-
tribute to the development and progres- sion 
of hepatocarcinogenesis through different 
mechanisms (Bishayee et al., 2010; He and 
Lin, 2017). Also, it has been reported that ole-
aster fruit possesses potent antioxidant and 
anti-inflammatory effects as well as antimuta-
genic and antitumour activities (Amiri Teh-
ranizadeh et al., 2016; Faramarz et al., 2015; 
Hamidpour et al., 2016). Therefore, it can be 
suggested that these biochemical properties 
are responsible, at least partly, for the chemo-
prevention of the fruit. On the other hand, fur-
ther studies to find out mechanisms underly-
ing the effect would be complementary to this 
study. The results of this study demonstrate 
that bioactive constituents from oleaster 
would be valuable for their use in the chemo-
prevention of liver cancer. However, we be-
lieve that further studies are required to eluci-
date what active compounds are responsible 
for the chemopreventive effect of this valua-
ble fruit and to detect synergy among the dif-
ferent components of oleaster. 
In conclusion, our results showed that ole-
aster has a chemopreventive effect against 
DEN-induced hepatocarcinogenesis in rats 
and this valuable fruit can be proposed as a 
promising candidate for HCC chemopreven-
tion. 
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